Antiaging Atlanta

Testosterone Abstracts

  1. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.
  2. Testosterone treatment enhances regional brain perfusion in hypogonadal men.
  3. Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss.
  4. Andropause: an old concept in new clothing.
  5. A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males.
  6. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
  7. Testosterone replacement therapy restores normal ghrelin in hypogonadal men.
  8. Erectile dysfunction: etiology and treatment in young and old patients.
  9. Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials.
  10. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.
  11. Male hypogonadism in the primary care clinic.
  12. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension.
  13. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men.
  14. Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial.
  15. Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men.
  16. Gonadal and erectile dysfunction in diabetics.
  17. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II.
  18. Current controversies in testosterone testing: aging and obesity.
  19. Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men.
  20. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.
  21. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study.
  22. Endocrine causes of impotence (nondiabetes).
  23. Testosterone and behavior.
  24. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment.
  25. Effects of androgen therapy on adipose tissue and metabolism in older men.
  26. Blood testosterone threshold for androgen deficiency symptoms.
  27. Current controversies in testosterone testing: aging and obesity.
  28. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study.
  29. Testosterone and depression in men aged over 50 years. Andropause and psychopathology: minimal systemic work-up.
  30. Androgens, andropause and neurodegeneration: exploring the link between steroidogenesis, androgens and Alzheimer's disease.
  31. Sex hormones and coronary artery disease.
  32. Lower endogenous androgens predict central adiposity in men.
  33. Effects of testosterone supplementation in the aging male.
  34. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants.
  35. Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients.
  36. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.
  37. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study.
  38. Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability.
  39. Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression.
  40. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease.
  41. Testosterone and atherosclerosis.
  42. The association of hypotestosteronemia with coronary artery disease in men.
  43. Sex hormone concentrations in men with angiographically assessed coronary artery disease--relationship to obesity and body fat distribution.
  44. Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men.
  45. Abnormalities in sex hormones are a risk factor for premature manifestation of coronary artery disease in South African Indian men.
  46. Sex hormones in men with coronary arteriosclerosis.
  47. Sex hormones and coronary artery disease.
  48. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men.
  49. Sex hormone levels in young Indian patients with myocardial infarction.
| Site Map | Links & Resources | Contact Us | ©2004 - 2005 Anti-Aging & Weight Loss Medicine, LLC - Disclaimer and Copyright